Live Quote · NASDAQLBRXHealthcare· Biotechnology

LB Pharmaceuticals Inc Common Stock

$38.85▼ 2.97%($-1.19)
MKT CAP $1.26BNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
70
Valuation
20
Profitability
60
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBRX research report →

Analyst Price Target
$59.78+53.9% vs. today

Range $35 – $80

Analyst RatingBuy
3 Buy1 Hold0 Sell

Price Chart

+146.04% · this period
$49.48$32.41$15.33Nov 20May 26Nov 20
52-Week Range68% of range
Low
$15.19
Current
$38.85
High
$50.16